Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression. - Archive ouverte HAL Access content directly
Journal Articles European Heart Journal Year : 2010

Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.

(1, 2) , (1, 2) , (1) , (1, 2) , (1, 2) , (3) , (3) , (1, 2) , (1, 2, 4) , (1, 2, 4)
1
2
3
4

Abstract

AIMS: To investigate the adaptations of left ventricular function and calcium handling to chronic heart rate reduction with ivabradine in the reperfused heart. METHODS AND RESULTS: Rabbits underwent 20 min coronary artery occlusion followed by 3 weeks of reperfusion. Throughout reperfusion, rabbits received ivabradine (10 mg/kg/day) or vehicle (control). Ivabradine reduced heart rate by about 20% and improved both ejection fraction (+35%) and systolic displacement (+26%) after 3 weeks of treatment. Interestingly, this was associated with a two-fold increase expression of FKBP12/12.6. There was no difference in the expressions of phospholamban, SERCA2a, calsequestrin, ryanodine, phospho-ryanodine, and Na(2+)/Ca(2+) exchanger in the two groups. Infarct scar and vascular density were similar in both groups. Administration of a single intravenous bolus of ivabradine (1 mg/kg) in control rabbits at 3 weeks of reperfusion also significantly improved acutely ejection fraction and systolic displacement. CONCLUSION: Chronic heart rate reduction protects the myocardium against ventricular dysfunction induced by myocardial ischaemia followed by 3 weeks of reperfusion. Beyond pure heart rate reduction, ivabradine improves global and regional systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term adaptation in calcium handling, as supported by the increase in FKBP12/12.6 expression.
Fichier principal
Vignette du fichier
Couvreur_et_al-HAL.pdf (243 Ko) Télécharger le fichier
Vignette du fichier
inserm-00500900_edited.pdf (591.86 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00500900 , version 1 (22-12-2010)

Identifiers

Cite

Nicolas Couvreur, Renaud Tissier, Sandrine Pons, Valérie Chetboul, Vassiliky Gouni, et al.. Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.. European Heart Journal, 2010, 31 (12), pp.1529-37. ⟨10.1093/eurheartj/ehp554⟩. ⟨inserm-00500900⟩
88 View
710 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More